Lista de obras - Anna Truini - Dominio Público Uruguay

A Novel Serum 4-microRNA Signature for Lung Cancer Detection.

scientific article published on 23 July 2015

Afatinib for the treatment of advanced non-small-cell lung cancer.

artículo científico publicado en 2014

Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.

artículo científico publicado en 2014

Belagenpumatucel-L for the treatment of non-small cell lung cancer

artículo científico

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.

artículo científico publicado en 2017

Classification of different patterns of pulmonary adenocarcinomas.

artículo científico

Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System

artículo científico publicado en 2014

Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism

artículo científico publicado en 2017

Efficacy of motesanib diphosphate in non-small-cell lung cancer

artículo científico publicado en 2014

Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma.

artículo científico publicado en 2013

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

artículo científico publicado en 2017

Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy.

artículo científico

Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.

artículo científico publicado en 2018

Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine

artículo científico

Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform

artículo científico publicado en 2015

Oral vinorelbine in the treatment of non-small-cell lung cancer.

artículo científico

Pemetrexed for the treatment of non-small cell lung cancer.

artículo científico publicado en 2013

Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.

artículo científico publicado en 2016

Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer.

artículo científico publicado en 2014

Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.

artículo científico

Role of microRNAs in malignant mesothelioma.

artículo científico

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.

artículo científico publicado en 2015

Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes

artículo científico publicado en 2014

Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma.

artículo científico publicado en 2015

Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report

artículo científico publicado en 2016

Lista de obras de Anna Truini

A Novel Serum 4-microRNA Signature for Lung Cancer Detection.

Afatinib for the treatment of advanced non-small-cell lung cancer.

Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.

Belagenpumatucel-L for the treatment of non-small cell lung cancer

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.

Classification of different patterns of pulmonary adenocarcinomas.

Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System

Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism

Efficacy of motesanib diphosphate in non-small-cell lung cancer

Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma.

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy.

Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.

Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine

Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform

Oral vinorelbine in the treatment of non-small-cell lung cancer.

Pemetrexed for the treatment of non-small cell lung cancer.

Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.

Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer.

Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.

Role of microRNAs in malignant mesothelioma.

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.

Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes

Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma.

Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report